Home > Healthcare > Point of Care Testing Market > Table of Contents

Point of Care Testing Market Size - By Product, By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-based Testing), By Application, By End-use – Global Forecast 2023 - 2032

  • Report ID: GMI3086
  • Published Date: Jul 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Base estimates & workings

1.2.1    Data collection

1.3    Forecast calculations

1.4    Data Sources

1.4.1    Primary

1.4.2    Secondary

1.4.2.1   Paid sources

1.4.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Global point of care testing market 360° synopsis, 2018 – 2032 (Revenue)

2.2    Business trends

2.3    Regional trends

2.4    Product trends

2.5    Technology trends

2.6    Prescription trends

2.7    Application trends

2.8    End-use trends

Chapter 3   Point of Care Testing Industry Insights

3.1    COVID- 19 impact analysis

3.2    Industry ecosystem analysis

3.3    Technology landscape

3.4    Pricing analysis, by cardiac markers, 2022

3.5    Regulatory landscape

3.6    Industry impact forces

3.6.1    Growth drivers

3.6.1.1   Upward trend in disease prevalence among developing countries

3.6.1.2   Surging number of pathology labs and services equipped with advanced diagnostic equipment in North America

3.6.1.3   Technological advancements

3.6.1.4   Increasing R&D investment

3.6.2    Industry pitfalls & challenges

3.6.2.1   Stringent regulatory framework

3.6.2.2   High cost of product development

3.7    Growth potential analysis

3.7.1    By product

3.7.2    By technology

3.7.3    By prescription

3.7.4    By application

3.7.5    By end-use

3.8    Porter's analysis

3.9    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company market share analysis, 2022 (by region)

4.2.1    Global market share analysis, 2022

4.2.2    North America

4.2.3    Europe

4.2.4    Asia Pacific

4.2.5    Latin America

4.2.6    MEA

4.3    Competitive analysis of major market players, 2022

4.4    Company positioning matrix, 2022

4.5    Strategy outlook matrix, 2022

Chapter 5   Point of Care Testing Market Estimates and Forecast, By Product (Revenue)

5.1    Key trends, by product

5.2    Glucose monitoring

5.2.1    Strips

5.2.2    Meters

5.2.3    Lancets

5.3    Cardiometabolic testing products

5.3.1    Cardiac marker testing products

5.3.1.1   hsTnl

5.3.1.2   BNP

5.3.1.3   D-dimer

5.3.1.4   CK-MB

5.3.1.5   Myoglobin

5.3.1.6   Others

5.3.2    Blood gas/electrolytes testing products

5.3.3    HBA1C testing products

5.4    Infectious disease testing products

5.4.1    Influenza testing products

5.4.2    HIV testing products

5.4.3    Hepatitis C testing products

5.4.4    Sexually transmitted disease (STD) testing products

5.4.5    Healthcare-associated infection (HAI) testing products

5.4.6    Respiratory infection testing products

5.4.7    Tropical disease testing products

5.4.8    Others

5.5    Coagulation testing products

5.5.1    PT/INR testing products

5.5.2    Activated clotting time (ACT/APTT) testing products

5.6    Pregnancy and fertility testing products

5.6.1    Pregnancy testing products

5.6.2    Fertility testing products

5.7    Tumor/cancer marker testing products

5.8    Cholesterol testing products

5.9    Hematology testing products

5.10    Drug-of-abuse (DoA) testing products

5.11    Fecal occult testing products

5.12    Urinalysis testing products

5.13    Others

Chapter 6   Point of Care Testing Market Estimates and Forecast, By Technology (Revenue)

6.1    Key trends, by technology

6.2    Lateral flow assays

6.3    Dipsticks

6.4    Microfluidics

6.5    Molecular diagnostics

6.6    Immunoassays

6.7    Agglutination assays

6.8    Flow-through

6.9    Solid phase

6.10    Biosensors

Chapter 7   Point of Care Testing Market Estimates and Forecast, By Prescription (Revenue)

7.1    Key trends, by prescription

7.2    OTC testing

7.3    Prescription-based testing

Chapter 8   Point of Care Testing Market Estimates and Forecast, By Application (Revenue)

8.1    Key trends, by application

8.2    Cardio metabolic testing

8.3    Infectious disease testing

8.4    Nephrology testing

8.5    Drug-of-abuse (DoA) testing

8.6    Blood glucose testing

8.7    Pregnancy testing

8.8    Cancer biomarker testing

8.9    Others

Chapter 9   Point of Care Testing Market Estimates and Forecast, By End-use (Revenue)

9.1    Key trends, by end-use

9.2    Hospitals

9.3    Diagnostic centers

9.4    Research laboratories

9.5    Home-care settings

9.6    Others

Chapter 10   Point of Care Testing Market Estimates and Forecast, By Region (Revenue)

10.1    Key trends, by region

10.2    North America

10.2.1    U.S.

10.2.2    Canada

10.3    Europe

10.3.1    Germany

10.3.2    UK

10.3.3    France

10.3.4    Italy

10.3.5    Spain

10.3.6    Switzerland

10.3.7    The Netherlands

10.3.8    Denmark

10.3.9    Poland

10.3.10    Sweden

10.4    Asia Pacific

10.4.1    China

10.4.2    Japan

10.4.3    India

10.4.4    Australia

10.4.5    South Korea

10.4.6    New Zealand

10.4.7    Thailand

10.4.8    Vietnam

10.4.9    Indonesia

10.5    Latin America

10.5.1    Brazil

10.5.2    Mexico

10.5.3    Argentina

10.5.4    Colombia

10.5.5    Chile

10.6    Middle East & Africa

10.6.1    Saudi Arabia

10.6.2    South Africa

10.6.3    UAE

10.6.4    Turkey

Chapter 11   Company Profiles

11.1    Abaxis

11.2    Abbott Laboratories

11.3    ACON Laboratories, Inc

11.4    Accubiotech Co, Ltd.

11.5    Becton, Dickinson and Company

11.6    bioLytical Laboratories Inc

11.7    BioMerieux SA

11.8    Bio-Rad Laboratories, Inc

11.9    HemoCue AB (Danaher Corporation)

11.10    Dexcom, Inc

11.11    Dragerwerk Ag & Co

11.12    LifeScan IP Holdings, LLC

11.13    Medtronic Plc

11.14    Meridian Bioscience

11.15    Nova Biomedical

11.16    OraSure Technologies

11.17    F. Hoffmann-La Roche

11.18    Siemens Healthineers AG

11.19    Sysmex Corporation

11.20    Trinity Biotech
 

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 20
  • Tables & Figures: 921
  • Countries covered: 30
  • Pages: 431
 Download PDF